Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase

Bioorganic & Medicinal Chemistry
Shiyang ZhouGangliang Huang

Abstract

In the studied a series novel of lazabemide derivatives were designed, synthesized and evaluated as inhibitors of monoamine oxidase (MAO-A or MAO-B). These compounds used lazabemide as the lead compound, and the chemistry structures were modified by used the bioisostere and modification of compound with alkyl principle. The two types of inhibitors (inhibition of MAO-A and inhibition of MAO-B) were screened by inhibition activity of MAO. In vitro experiments showed that compounds 3a, 3d and 3f had intensity inhibition the biological activity of MAO-A, while compounds 3i and 3m had intensity inhibition the biological activity of MAO-B. It could be seen from the data of inhibition activity experiments in vitro, that the compound 3d was IC50 = 3.12 ± 0.05 μmol/mL of MAO-A and compound 3m was IC50 = 5.04 ± 0.06 μmol/mL. In vivo inhibition activity experiments were conducted to evaluate the inhibitory activity of compounds 3a, 3d, 3f, 3i and 3m by detecting the contents of 5-HT, NE, DA and activity of MAO-A and MAO-B in plasma and brain tissue. In vivo inhibition activity evaluation results showed that the compounds 3a, 3d, 3f, 3i and 3m had increased the contents of 5-HT, NE and DA in plasma and brain tissues. Meanwhile, the determi...Continue Reading

References

May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J GrimsbyJ C Shih
May 24, 2001·The Journal of Biological Chemistry·I RebrinJ C Shih
Dec 26, 2001·Nature Structural Biology·Claudia BindaAndrea Mattevi
Nov 9, 2005·Expert Review of Neurotherapeutics·Claire HenchcliffeF Tuna Burgut
Dec 17, 2005·Bioorganic & Medicinal Chemistry Letters·Seham Y HassanAdel Amer
Jan 13, 2006·British Journal of Pharmacology·Moussa B H Youdim, Y S Bakhle
Jan 1, 1928·The Biochemical Journal·M L Hare
Feb 14, 2007·The American Journal of Geriatric Pharmacotherapy·David R P Guay
Sep 25, 2009·The New England Journal of Medicine·C Warren OlanowUNKNOWN ADAGIO Study Investigators
Aug 12, 2010·Current Pharmaceutical Design·Makoto Naoi, Wakako Maruyama
Jul 12, 2012·Cellular and Molecular Life Sciences : CMLS·Chi Chiu WangChristoph Ufer
Jan 8, 2014·European Journal of Medicinal Chemistry·Cecilia MattssonClas Sonesson
Oct 6, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Karen RitchieCraig W Ritchie
Apr 6, 2017·Toxicology and Applied Pharmacology·Anzelle DelportJacobus P Petzer
Jun 7, 2017·European Journal of Pharmacology·Gabriel OancaJanez Mavri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Sherine Nabil KhattabFernando Albericio
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
X ChenB X Wang
© 2022 Meta ULC. All rights reserved